Spectaire Holdings closes $2M equity investment

Spectaire has announced that it has closed a $2.0 million private placement with True Remainders Ltd. for the sale and issuance of an aggregate of 1,538,461 shares of Spectaire common stock, and an accompanying warrant to purchase up to 1,538,461 shares of Spectaire common stock at an exercise price of $1.30 per share. The Warrant is immediately exercisable and may be exercised at any time until March 18, 2027. “I am a long-term shareholder and believe in the future of Spectaire,” said John Hultink, founder of True Remainders. “I have a firm belief that any company that has miniaturized an instrument such as a mass spectrometer, and has successfully deployed the technology, will have a great future. I look forward to continuing to support Spectaire as the company progresses.”